Mesa Laboratories, Inc.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $3.4M | $-254.6M | $2.1M | $-1.2M | $-549.0K | $611.0K | $451.0K | $1.3M |
| Depreciation & Amortization | — | — | — | $8.1M | $8.1M | $9.1M | $8.6M | $8.1M |
| Depreciation | $1.4M | $1.3M | $1.1M | $911.0K | $914.0K | — | — | — |
| Amortization | $4.1M | $5.0M | $8.0M | $7.2M | $7.2M | $7.2M | $7.1M | $7.1M |
| Stock-Based Compensation | $2.9M | $2.8M | $3.0M | $3.2M | $3.0M | $2.7M | $2.1M | $4.4M |
| Net Cash from Operating Activities | $10.7M | $12.9M | $11.5M | $9.8M | $9.9M | $12.5M | $7.7M | $10.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $891.0K | $535.0K | $1.1M | $634.0K | $270.0K | $1.0M | $1.7M | $1.6M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-891.0K | $426.0K | $-80.8M | $-634.0K | $-270.0K | $-1.0M | $-6.6M | $-1.6M |
| Financing Activities | ||||||||
| Dividends Paid | $863.0K | $864.0K | $862.0K | $862.0K | $859.0K | $856.0K | $855.0K | $852.0K |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-9.4M | $-12.9M | $60.8M | $-5.6M | $-9.5M | $-4.4M | $-8.9M | $-18.6M |
| Net Change in Cash | $258.0K | $-10.0K | $-7.4M | $3.2M | $-534.0K | $6.8M | $-6.3M | $-11.4M |
| Free Cash Flow | $9.9M | $12.3M | $10.4M | $9.1M | $9.7M | $11.5M | $6.1M | $8.9M |